Shares of Owens & Minor (NYSE: OMI) surged 9.41% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The healthcare solutions company reported earnings that surpassed analyst expectations and provided an optimistic outlook for the full year.

Owens & Minor announced an adjusted earnings per share (EPS) of $0.23 for Q1, beating the consensus estimate of $0.20 by 15%. This represents a 21.05% increase from the same period last year. The company's adjusted net income reached $18.1 million, significantly exceeding the estimated $15.5 million. Additionally, adjusted EBITDA came in at $121.9 million, surpassing the projected $114.4 million.

While Q1 revenue slightly missed expectations at $2,632 million compared to the estimated $2,658 million, investors seemed to focus on the company's strong bottom-line performance and positive outlook. Owens & Minor provided full-year 2025 guidance, projecting revenue between $10,850 million and $11,150 million, adjusted EPS of $1.60 to $1.85, and adjusted EBITDA ranging from $560 million to $590 million. The company also revealed that it remains actively engaged in the potential sale of its Products & Healthcare Services segment, which could further streamline operations and unlock shareholder value.